Novlead Biotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 158

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 18

Novlead Biotech General Information

Description

Developer and manufacturer of medical devices designed for cardiopulmonary, respiratory and anti-infection fields. The company focuses on the medical application of nitric oxide (NO) to treat pulmonary hypertension and infectious diseases, enabling hospitals to improve treatment efficiency and quality of patient's life.

Contact Information

Website
www.novlead.com
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Nanjing Jiangbei New Area R&D and Production Headquarters
  • Nanjing, Jiangsu 211800
  • China
+86 400
Primary Industry
Therapeutic Devices
Corporate Office
  • Nanjing Jiangbei New Area R&D and Production Headquarters
  • Nanjing, Jiangsu 211800
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novlead Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. IPO 20-Feb-2026 Announced Clinical Trials - General
7. Later Stage VC (Series C) 20-Feb-2024 Completed Clinical Trials - General
6. Early Stage VC (Series B1) 08-Sep-2022 Completed Clinical Trials - General
5. Early Stage VC (Series B) 15-Nov-2021 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) 19-Dec-2020 Completed Pre-Clinical Trials
3. Early Stage VC 26-Apr-2020 Completed Product Development
2. Secondary Transaction - Private 21-Feb-2020 Completed Product Development
1. Merger/Acquisition 06-Mar-2019 $44.5K Completed Product Development
To view Novlead Biotech’s complete valuation and funding history, request access »

Novlead Biotech Patents

Novlead Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4724126-A1 Apparatuses, systems, and methods for transmitting therapeutic gas Pending 06-Jun-2023
US-20260325771-A1 Apparatuses, systems, and methods for transmitting therapeutic gas Pending 06-Jun-2023
WO-2024251144-A1 Apparatuses, systems, and methods for transmitting therapeutic gas Inactive 06-Jun-2023
AU-2023416236-A1 On-demand nitric oxide generation and delivery devices Pending 28-Dec-2022
EP-4642956-A1 On-demand nitric oxide generation and delivery devices Pending 28-Dec-2022 C25B1/01
To view Novlead Biotech’s complete patent history, request access »

Novlead Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novlead Biotech Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Partnerships Venture Capital Minority
Jiangsu Dingxin Capital Management Venture Capital Minority
Shenzhen Yifeng Investment Management Enterprise Venture Capital Minority
Triwise Capital Venture Capital Minority
Xingxiang Investment Holding Group Asset Manager Minority
You’re viewing 5 of 18 investors. Get the full list »

Novlead Biotech FAQs

  • When was Novlead Biotech founded?

    Novlead Biotech was founded in 2018.

  • Where is Novlead Biotech headquartered?

    Novlead Biotech is headquartered in Nanjing, China.

  • What is the size of Novlead Biotech?

    Novlead Biotech has 158 total employees.

  • What industry is Novlead Biotech in?

    Novlead Biotech’s primary industry is Therapeutic Devices.

  • Is Novlead Biotech a private or public company?

    Novlead Biotech is a Private company.

  • What is Novlead Biotech’s current revenue?

    The current revenue for Novlead Biotech is .

  • How much funding has Novlead Biotech raised over time?

    Novlead Biotech has raised $60.1M.

  • Who are Novlead Biotech’s investors?

    Innovation Partnerships, Jiangsu Dingxin Capital Management, Shenzhen Yifeng Investment Management Enterprise, Triwise Capital, and Xingxiang Investment Holding Group are 5 of 18 investors who have invested in Novlead Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process